Clinical deterioration during antituberculosis treatment in Africa: Incidence, causes and risk factors
Open Access
- 30 March 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 10 (1), 83
- https://doi.org/10.1186/1471-2334-10-83
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health responseThe Lancet, 2009
- Novel Relationship between Tuberculosis Immune Reconstitution Inflammatory Syndrome and Antitubercular Drug ResistanceClinical Infectious Diseases, 2009
- Clinical Deterioration during Antitubercular Treatment at a District Hospital in South Africa: The Importance of Drug Resistance and AIDS Defining IllnessesPLOS ONE, 2009
- Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settingsThe Lancet Infectious Diseases, 2008
- Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date reviewJournal of Gastroenterology and Hepatology, 2007
- Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy studyAIDS, 2007
- WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, UgandaAIDS, 2007
- Determinants of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Pharmacokinetics in a Cohort of Tuberculosis PatientsAntimicrobial Agents and Chemotherapy, 2006
- Morbidity and Mortality in South African Gold Miners: Impact of Untreated Disease Due to Human Immunodeficiency VirusClinical Infectious Diseases, 2002
- Efficacy of Trimethoprim–Sulfamethoxazole for the Prevention of Bacterial Infections in a Randomized Prophylaxis Trial of Patients with Advanced HIV InfectionAIDS Research and Human Retroviruses, 2002